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Abstract
Introduction The purpose of this study was to quantify the
reduction in patient radiation dose by X-ray imaging technol-
ogy using image noise reduction and system settings for
neuroangiography and to assess its impact on the working
habits of the physician.
Methods Radiation dose data from 190 neuroangiographies
and 112 interventional neuroprocedures performed with state-
of-the-art image processing and reference system settings
were collected for the period January–June 2010. The system
was then configured with extra image noise reduction algo-
rithms and system settings, which enabled radiation dose
reduction without loss of image quality. Radiation dose data
from 174 neuroangiographies and 138 interventional neuro-
procedures were collected for the period January–June 2012.
Procedures were classified as diagnostic or interventional.
Patient radiation exposure was quantified using cumulative
dose area product and cumulative air kerma. Impact on work-
ing habits of the physician was quantified using fluoroscopy
time and number of digital subtraction angiography (DSA)
images.
Results The optimized system settings provided significant
reduction in dose indicators versus reference system settings
(p<0.001): from 124 to 47 Gy cm2 and from 0.78 to 0.27 Gy
for neuroangiography, and from 328 to 109 Gy cm2 and from
2.71 to 0.89 Gy for interventional neuroradiology. Differences
were not significant between the two systems with regard to
fluoroscopy time or number of DSA images.
Conclusion X-ray imaging technology using an image noise
reduction algorithm and system settings provided approxi-
mately 60% radiation dose reduction in neuroangiography
and interventional neuroradiology, without affecting the work-
ing habits of the physician.
Keywords Angiography . Radiation dose . Radiation
physics . Imaging technology . Interventional neuroradiology
Introduction
Complex neurovascular procedures may expose patients and,
secondarily, staff to high doses of ionizing radiation. The
potential consequences, such as erythema and hair loss, are
of major concern [1]. However, in accordance with the as low
as reasonably achievable (ALARA) principle, radiation doses
cannot be reduced below the level necessary for acceptable
clinical image quality.
An X-ray imaging technology using advanced image noise
reduction algorithms combined with optimized system set-
tings that enable dose reduction and optimal image quality
was designed for digital subtraction angiography (DSA) and
fluoroscopy in neuroradiology, in order to reduce patient
radiation dose without impairing image quality (AlluraClarity;
Philips Healthcare, Best, Netherlands). A previous study
addressed non-inferiority of image quality in DSA at 75%
radiation dose reduction [2]. The current study aims to quan-
tify the radiation dose reduction in a patient cohort subjected
to diagnostic neuroangiography or interventional neuroradiol-
ogy and to test the hypothesis that the image noise reduction
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algorithms with optimized system settings would significantly
reduce patient radiation exposure without affecting parameters
such as fluoroscopy time and number of DSA images (“the
working habits of the physician”).
Methods
The study was approved by the local Ethical Review Board at
Karolinska University Hospital, Stockholm, Sweden.
Data acquired on a system equipped with a state-of-the-art
image processing with reference system settings (“reference
system”) was compared with data from the same system
equipped with advanced image noise reduction algorithms
combined with optimized system settings (“current system”).
Procedure and dose data for the reference system and the
current system were collected during January–June 2010 and
January–June 2012, respectively. The same radiologists were
employed and the same procedural techniques were used.
All examinations were performed on the same biplane flat
panel detector angiography system (AlluraXper FD20/20 bi-
plane; Philips Healthcare), equipped during the second part of
the study with an image processing chain for noise reduction
in DSA and fluoroscopy, combined with optimized system
settings (AlluraClarity; Philips Healthcare).
The image processing chain uses several features to improve
image quality. The real-time automatic pixel shift feature is used
to reduce the anatomical structure noise which is introduced in
the subtracted image by patient motion or accidental table
motion. By minimizing this undesired noise source, quantum
noise will become the dominant noise source in DSA images.
Another feature is the temporal averaging of consecutive
images to create a combined mask and a combined live image.
Temporal averaging will reduce the amount of temporally
uncorrelated noise such as quantum noise. Contrast detection
functionality will reveal changes in the iodine bolus location
and prevent this from being “diluted” by the averaging.
In the spatial noise reduction feature, the first analysis
phase aims to reveal the predominant signal structures in the
image, which will be excluded from the low-pass spatial filter
in the second phase. The combination of phases will smooth
only the parts of the image which are considered featureless.
More details about the features are described in Söderman
et al. [2].
Optimization of system settings for DSA acquired with the
current system included typical tube voltage 75 kVp, addi-
tional 0.1 mm Cu+1 mm Al filter, detector dose of 0.7 μGy/fr
on largest field of view and 0.4 mm focal spot size [2].
Depending on the average equivalent water thickness,
the patient dose reduction for fluoroscopy, due to the low-
exposure acquisition settings of the current system, can range
from approximately 10% for small equivalent water thickness
to approximately 50% for large equivalent water thickness,
achieved, for example, with steeper projections. The average
equivalent water thickness for the head is considered approx-
imately 22 cm on the frontal plane and 18 cm for the lateral
plane, over the full population range [3]. For this average
water equivalent thickness, the expected patient dose reduc-
tion is 30%.
Patients were subjected to neuroangiography or endovascular
treatment during the study periods. Patient demographics and
procedure information were collected. Patients were categorized
as being subjected to diagnostic or interventional procedures.
Interventional procedures were further divided in subgroups: (a)
arteriovenous malformation (AVM), (b) aneurysm, (c) stroke
and (d) others.
Table 1 Patient demographics
CI confidence interval, SD stan-
dard deviation
a p -Value (two-sided) from
ANOVA for continuous parame-
ters, and from Chi-squared test for
categorical parameters
b The number of interventions
was 112 for the reference system,










Mean±SD 51.6±17.6 56.5±17.4 54.1±17.7
95% CI 49.6–53.6 54.6–58.4 52.7–55.5
Median 53.0 59.0 56.0
Min–Max 0–91 1–91 0–91
Procedure duration (min) 0.212
Mean±SD 58.5±54.0 64.2±58.9 61.4±56.6
95% CI 52.4–64.6 57.6–70.8 56.9–65.9
Median 35.0 40.0 39.5
Min–Max 5–260 5–325 5–325
Intervention procedures,b n (%) 0.232
AVM 9 (8.0) 4 (2.9) 13 (5.2)
Aneurysm 26 (23.2) 38 (27.5) 64 (25.6)
Stroke 41 (36.6) 45 (32.6) 86 (34.4)
Other 36 (32.1) 51 (37.0) 87 (34.8)
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Patient radiation dose indicators, quantified as (cumulative)
dose area product (DAP) and cumulative air kerma (CAK), as
well as acquisition parameters, such as number of DSA im-
ages, fluoroscopy time, procedure time, and number of DSA
runs, were collected.
The equipment displayed the updated cumulative dose-area
product (DAP), measured by the internal transmission ioniza-
tion chambers (KermaX plus; IBADosimetry, Schwarzenbruck,
Germany) configured in both planes.
The inherent dose-report system in the angiography equip-
ment provided information, measured in Gy cm2, of DAP
fluoroscopy, DAP exposure, and total DAP (sum of DAP
fluoroscopy and DAP exposure). DAP exposure indicated
the DAP for all DSA acquisitions stored in the system.
CAK at the patient entrance reference point for frontal and
lateral channels was provided in Gy. This information was
sent via modality performance procedure step (MPPS)
automatically to the radiology information system (RIS;
Carestream, Vaughan, Canada)
The primary outcome of the study was radiation dose quan-
tified as DAP and CAK. Secondary outcomes were fluorosco-
py time, number of DSA images, number of DSA runs, and
procedure duration.
Statistical analysis
Descriptive statistics were used to describe patient and proce-
dure characteristics, with differences between reference and
current system evaluated with one-way analysis of variance
(ANOVA) models at a significance level of α=0.05. Differ-
ences in exposure between the reference and the current
systemswere compared using ANOVAwith least squaremean
dose values, using an F -test. Secondary covariance analyses
were performed for DAP, CAK, and acquisition measures
Fig. 1 Distribution of DAP
values for diagnostic procedures.
Dashed lines represent third
quartile (Q3). For graph layout
purposes, the x-axis is limited to
410 Gy cm2, with 5% of the
procedures for the reference
system not being displayed on the
scale (max value is 2,997 Gy cm2)
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(analysis of covariance) to determine potential impact of de-
mographic differences or type of intervention.
Results
Subjects
A total of 620 patients were included in the data collection;
however, 4 patients were excluded because the radiation dose
data information was incomplete, and 2 patients were exclud-
ed because they were classified as diagnostic and treatment
together. Therefore, 614 patients were analyzed. Patient base-
line characteristics are summarized in Table 1. The reference
system group included 302 patients (172 females and 130
males) divided in 190 diagnostic and 112 interventional pro-
cedures. The current system group included 312 patients (172
females and 140 males) divided in 174 diagnostic and 138
interventional procedures. For both groups, the number of
AVMs is very small; therefore, procedural dose reduction
will not be calculated. The mean age for both groups was
54.1±17.7 years; however, patients treated with the current
systemwere older than those treated with the reference system
(p<0.001).
Cumulative DAP
DAP values were highly skewed with large variability (Figs. 1
and 2). Patient exposure and number of images were higher
for interventional procedures compared with diagnostic pro-
cedures. For diagnostic procedures, median total DAP and
median DAP exposure with the current system decreased from
124 to 47 Gy cm2 and from 113 to 36 Gy cm2, respectively
(Table 2). Both reductions were significant (p<0.001). Based
on geometric means, the patient radiation dose reduction was
62% for total DAP and 69% for DAP exposure.
Fig. 2 Distribution of DAP
values for interventional
procedures. Dashed lines
represent third quartile. For graph
layout purposes, the x-axis is
limited to 900 Gy cm2, with 5%
of the procedures for the reference
system not being displayed on the
scale (max value is 1,114Gy cm2)
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For interventional procedures, there was a dose reduction
from 328 to 109 Gy cm2 for total DAP, from 70 to 42 Gy cm2
for DAP fluoroscopy, and from 253 to 66 Gy cm2 for DAP
exposure, based on median values (Table 2); the differences
were significant (p<0.001). Based on geometric means, the
patient radiation dose reduction was 65%, 33%, and 73% for
total DAP, DAP fluoroscopy, and DAP exposure, respectively.
For both diagnostic and interventional procedures, the first
quartile (Q1) DAP for the reference system exceeded the third
quartile (Q3) of the DAP for the current system, except for
DAP fluoroscopy.
Regardless of the interventional subgroup, DAP values
decreased. The dose reduction (total DAP) was approximately
70%, 60%, and 65% for aneurysm, stroke, and other catego-
ries, respectively, based on geometric means.
Secondary analyses were performed to evaluate the impact
of age on DAP values because patient age was statistically
significantly different between the reference system and cur-
rent system group, for interventional procedures. There was
no effect of age on DAP in the interventional procedure group
(p=0.2597).
Cumulative air kerma
CAK values were highly skewed with large variability. For
diagnostic angiographies the median CAK values were re-
duced from 0.78 to 0.27 Gy for frontal and lateral channel
together, with reduction from 0.59 to 0.21Gy and from 0.19 to
0.06 Gy for the frontal and lateral channels, respectively
(Table 3); the difference was significant (p<0.001). The dose
reduction for the diagnostic procedures was 62% on the fron-
tal channel and 67% on the lateral channel based on geometric
Table 2 Descriptive summary of
DAP values for diagnostic and
interventional procedures
CI confidence interval, SD stan-











DAP fluoroscopy, (Gy cm2)
Mean±SD 17.2±45.7 14.6±20.8 85.4±68.5 55.5±47.3
Median 9 8 70 42
Q1–Q3 6–17 5–15 33–119 21–75
Min–Max 1–593 1–179 1–291 1–245
95% CI 10.7–23.8 11.5–17.7 72.6–98.3 47.5–63.4
DAP exposure (Gy cm2)
Mean±SD 145.2±190.0 46.1±39.8 304.5±199.3 86.2±71.0
Median 113 36 253 66
Q1–Q3 72–161 22–56 172–386 39–118
Min–Max 18–2,404 1–247 19–952 7–455
95% CI 118.0–172.4 40.2–52.1 267.2–341.8 74.2–98.1
Total DAP (Gy cm2)
Mean±SD 162.2±231.7 60.4±51.1 389.9±247.0 141.7±106.6
Median 124 47 328 109
Q1–Q3 78–179 28–76 225–518 67–196
Min–Max 21–2,997 7–325 28–1,114 8–635
95% CI 129.0–195.4 52.8–68.1 343.7–436.2 123.7–159.6













n=190 n=174 n=111 n=138
Mean±SD 0.78±0.89 0.31±0.33 2.56±1.74 0.97±0.89
Median 0.59 0.21 2.06 0.68
Q1–Q3 0.35–0.91 0.13–0.37 1.22–3.65 0.38–1.35
Min–Max 0.08–10.48 0.03–2.21 0.27–7.34 0.04–5.15
95% CI 0.65–0.91 0.26–0.36 2.23–2.89 0.82–1.12
CAK lateral
channel, Gy
n=188 n=170 n=111 n=135
Mean±SD 0.26±0.28 0.10±0.16 0.94±0.86 0.38±0.51
Median 0.19 0.06 0.65 0.21
Q1–Q3 0.11–0.31 0.03–0.11 0.32–1.25 0.10–0.45
Min–Max 0.02–2.88 0.00–1.49 0.06–4.86 0.01–3.18
95% CI 0.22–0.30 0.07–0.12 0.78–1.10 0.29–0.47
CI confidence interval, SD standard deviation,Q1 first quartile,Q3 third
quartile
Neuroradiology (2013) 55:1365–1372 1369
means. The median CAK values for interventional procedures
diminished from 2.71 to 0.89 Gy for frontal and lateral chan-
nel together, with reduction from 2.06 to 0.68 Gy and from
0.65 to 0.21 Gy for frontal and lateral channels, respectively.
The difference was significant (p<0.001). The dose reduction
was 66% on the frontal channel and 67% on the lateral
channel based on geometric means.
Regardless of the interventional subgroup, CAK values
were reduced for both frontal and lateral channels. Age had
no impact on CAK for patients subjected to interventional
procedures. In general, intervention type did not affect CAK
analyses.
Acquisition parameters
Acquisition parameter data showed a large variability. Fluo-
roscopy time and number of exposure images obtained were
substantially higher for interventional procedures (Table 4).
The difference in fluoroscopy time, number of DSA images,
number of DSA runs, and procedure duration did not reach
statistical significance.
Discussion
The aim of the study was to quantify the impact of X-ray
imaging technology using image noise reduction image pro-
cessing combined with optimized system settings on patient
radiation dose indicators and to assess its effects on the work-
ing habits of the physician.
This study confirmed dose reduction for DAP exposure to
be 69% and 73% for diagnostic and interventional procedures,
respectively, based on geometric means. Similar results were
obtained in previously published work where comparison was
based on two DSA acquisitions, performed with reference and
current system settings, on the same patient [2]. Patient dose
reduction in fluoroscopy was 33% for interventional neurora-
diology based on geometric means. For diagnostic and inter-
ventional procedures together, patient radiation dose reduction
for total DAP (sum of DAP fluoroscopy and DAP exposure)
and CAK was approximately 60%. Fluoroscopy time and
number of DSA images were both unaffected.
Similar to published analyses of patient exposure in inter-
ventional neuroradiology [3–7], this study reported wide var-
iability in radiation exposure and acquisition parameters, with
variation per procedure type [8] and diagnostic versus inter-
ventional procedure [3, 9, 10]. Comparison with other studies
is troublesome because metrics used are often different. Some
authors report peak skin dose, measured or estimated [11, 12],
whereas we report DAP and CAK as displayed by the angi-
ography system.
The RAD-IR study [4] reports meanDAP values of 320 Gy
cm2 for 382 cases including embolization of aneurysm and
AVM. Vano et al. [7] reports a mean DAP value of 305 Gy
cm2 and a median DAP value of 256 Gy cm2 for 172 embo-
lization procedures. However, D’Ercole et al. [5] reports a
higher median value of 352 Gy cm2 for 82 procedures. The
RAD-IR study [4] also reported CAK values of 3.8 Gy for
interventional neuroradiology procedures among patients with
AVM and aneurysm. The study by Vano et al. [7] reported a
CAKmedian of 2.4 Gy and a CAK third quartile (Q3) value of
3.9 Gy for cerebral embolizations. These data are in agree-
ment with our results obtained with reference dose settings.
The 2009 Society of Interventional Radiology guidelines
[13] recommend operators to be notified anytime CAK values
exceed 3 Gy and then every 1 Gy thereafter, or anytime DAP
Table 4 Descriptive summary of
acquisition settings for diagnostic
and interventional procedures
CI confidence interval, SD stan-











No. of acquired exposures/DSA images
Mean±SD 291.7±181.3 310.6±192.5 625.8±445.2 635.7±506.1
Median 266 278 525 464
Q1–Q3 160–385 173–402 292–870 299–845
Min–Max 30–1,096 1–1,434 50–2,327 108–2,986
95% CI 265.8–317.6 281.7–339.4 542.5–709.2 550.5–720.9
Fluoroscopy time (min)
Mean±SD 7.1±4.2 7.2±4.5 12.5±6.4 11.0±6.6
Median 6 6 13 12
Q1–Q3 4–9 4–9 7–17 5–16
Min–Max 0–22 0–22 1–24 0–23
95% CI 6.5–7.7 6.6–7.9 11.3–13.7 9.9–12.1
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exceeds 300 Gy cm2, and subsequently at increments of
100Gy cm2. Less than 4% of diagnostic procedures performed
with reference system exceeded the threshold values for CAK
(sum of frontal and lateral channels) and about 9% exceeded
the threshold for DAP. Only in 1% of the cases undergoing
diagnostic procedures performed with the current system
exceeded the threshold for CAK, and <1% exceeded the
threshold for DAP. However, about 47% of interventional
procedures performed with the reference system exceeded
CAK values, and 58% exceeded DAP threshold values. The
RAD-IR study reported 55% and 67% of AVM and aneurysm
procedures to be greater than 3 Gy [4]. The percentage of
interventional procedures performed with the current system
that exceeded the threshold values was reduced; CAK thresh-
old is exceeded in 10% of cases, whereas DAP in 8% of cases.
In this study, DSA provides about 70–80% of the total
procedure dose. Other studies report similar values [2, 14]
including the baseline study that this study is based on. With
the patient radiation dose reduction in DSA seen with the
current system, the relation fluoroscopy–DSA changes mak-
ing the contribution of fluoroscopy equally relevant on total
procedure radiation load (fluoroscopy contributes for about
40% and DSA for about 60%).
Limitations to the study
Interpreting data from this study is limited by those factors
inherent to retrospective design including the inability to
match patients. In addition, the clinical complexity of the
procedure and comparative image quality has not been taken
into account in the study. Although data were obtained at the
same facility with the same clinical staff for the two recording
periods, it was not possible to determine if other patient
dose reduction measures, such as further collimation, were
implemented in the current system group. However, the re-
duction in DAP exposure observed in this study is in the same
range as that observed in a previously published work, where
comparison was based on the same patient for DSA acquisi-
tion [2]. Thus the patient dose reduction is likely the effect of
the optimized system settings.
Conclusion
The image noise reduction X-ray imaging technology in com-
bination with optimized system settings, which enable dose
reduction and optimal image quality, reduced patient radiation
doses in DSA and fluoroscopy by approximately 60%; there
was no impact on physician working habits.
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